Pandemic cannot delay cancer diagnosis and control – Health

0
4


Security measures to prevent the transmission of covid-19 are necessary and have managed to prevent the feared collapse of the health system in the country. But the fear of contamination ended up dangerously delaying diagnoses, surgeries, treatments and other care in the routine of those who have cancer .

To have an idea of ​​what this may represent in the future, just consider that, in 2020, more than 600 thousand new cases of the disease are expected in Brazil, according to the projection of the National Cancer Institute (Inca).1 It is worrying, therefore, the estimate that more than 50 thousand diagnoses were not made between March and May.2 With this damming, experts fear that the post-pandemic may be marked by a significant increase in the rate of tumors identified at a more advanced stage.

To reverse this perspective, a coalition formed by Janssen, a pharmaceutical company from Johnson & Johnson, and patient associations and medical societies launched the campaign #TudoBemTratar cancer. The name, as it turns out, is a reference to the popular #TBT, Throwback Thursday – the movement to publish souvenirs on social networks on Thursdays, but reframed for Mondays, a day that represents new beginnings. The initiative brought together the Brazilian Association of Hematology, Hemotherapy and Cell Therapy (ABHH), the Brazilian Society of Urology (SBU), Oncoguia, the International Myeloma Foundation (IMF), the Vencer o Câncer Institute and the Instituto Lado a Lado pela Vida to warn you: the pandemic cannot delay cancer screening tests, let alone justify stopping treatments.

“The scenario of uncertainty causes fear and anxiety in many people. The prevention of contamination by the virus is extremely important, but it is not the only attention we have to pay to our health at this moment ”, reinforces Fabio Lawson, medical director at Janssen Brasil.

Among the actions, the #TudoBemTratar cancer promotes publications on the social networks of Janssen and other campaign partners with guidance on precautions to continue taking care of health without taking risks. In addition, the Patient Safety Guide and the Health Professional Safety Guide were developed, publications that highlight new fundamental attitudes and adaptations in this period.

“The campaign educates, engages and shows that the institutions are prepared to receive patients with all the necessary protection”, says Luciana Holtz, president of Instituto Oncoguia. “And it does it lightly, something that we need a lot today”, he concludes.

Access the guides at the link: https://www.janssen.com/brazil / blog / tbt

References

1 National Cancer Institute (Inca). Estimate 2020 Cancer Incidence in Brazil. (https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimate-2020-incidence-of-cancer-no-brasil.pdf)

2 Medical societies point to a 70% reduction in surgeries and that 50,000 Brazilians have not been diagnosed with cancer. (https://sbco.org.br/2020/05/14 / medical-societies-point-70-reduction-of-surgeries-and-that-50-thousand-brazilians-not-received-diagnosis-of-cancer/)



LEAVE A REPLY

Please enter your comment!
Please enter your name here